Education
About Us
Working with TipRanks
Follow Us
Enzo Biochem (ENZ)
NYSE:ENZ
Total Valuation
Enzo Biochem has a market cap or net worth of $16.77M. The enterprise value is -$2.62M.
Market Cap$16.77M
Enterprise Value-$2.62M
Share Statistics
Enzo Biochem has 52,402,805 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding52,402,805
Owned by Insiders12.08%
Owned by Institutions0.03%
Financial Efficiency
Enzo Biochem’s return on equity (ROE) is -0.46 and return on invested capital (ROIC) is -15.86%.
Return on Equity (ROE)-0.46
Return on Assets (ROA)-0.30
Return on Invested Capital (ROIC)-15.86%
Return on Capital Employed (ROCE)-0.16
Revenue Per Employee255.26K
Profits Per Employee-208.62K
Employee Count125
Asset Turnover0.37
Inventory Turnover2.53
Valuation Ratios
The current PE Ratio of Enzo Biochem is -2.23. Enzo Biochem’s PEG ratio is 0.02.
PE Ratio-2.23
PS Ratio0.88
PB Ratio0.93
Price to Fair Value1.03
Price to FCF-1.83
Price to Operating Cash Flow-1.97
PEG Ratio0.02
Income Statement
In the last 12 months, Enzo Biochem had revenue of 31.91M and earned -26.08M in profits. Earnings per share was -0.51.
Revenue31.91M
Gross Profit14.63M
Operating Income-9.82M
Pretax Income-9.82M
Net Income-26.08M
EBITDA-8.35M
Earnings Per Share (EPS)-0.51
Cash Flow
In the last 12 months, operating cash flow was -14.96M and capital expenditures -784.00K, giving a free cash flow of -15.75M billion.
Operating Cash Flow-14.96M
Free Cash Flow-15.75M
Free Cash Flow per Share-0.30
Dividends & Yields
Enzo Biochem pays an annual dividend of $0.1, resulting in a dividend yield of ―
Dividend Per Share$0.1
Dividend Yield―
Payout Ratio-24.45%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.21
52-Week Price Change-52.48%
50-Day Moving Average0.43
200-Day Moving Average0.81
Relative Strength Index (RSI)61.70
Average Volume (3m)455.96K
Important Dates
Enzo Biochem upcoming earnings date is Jun 16, 2025, TBA Not Confirmed.
Last Earnings DateMar 17, 2025
Next Earnings DateJun 16, 2025
Ex-Dividend DateNov 15, 2024
Financial Position
Enzo Biochem as a current ratio of 2.82, with Debt / Equity ratio of 8.92%
Current Ratio2.82
Quick Ratio2.55
Debt to Market Cap<0.01
Net Debt to EBITDA5.85
Interest Coverage Ratio-49.83
Taxes
In the past 12 months, Enzo Biochem has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Enzo Biochem EV to EBITDA ratio is -1.10, with an EV/FCF ratio of -0.34.
EV to Sales0.29
EV to EBITDA-1.10
EV to Free Cash Flow-0.34
EV to Operating Cash Flow-0.35
Balance Sheet
Enzo Biochem has $40.30M in cash and marketable securities with $3.14M in debt, giving a net cash position of -$37.16M billion.
Cash & Marketable Securities$40.30M
Total Debt$3.14M
Net Cash-$37.16M
Net Cash Per Share-$0.71
Tangible Book Value Per Share$1.10
Margins
Gross margin is 37.24%, with operating margin of -30.77%, and net profit margin of -81.73%.
Gross Margin37.24%
Operating Margin-30.77%
Pretax Margin-30.77%
Net Profit Margin-81.73%
EBITDA Margin-26.16%
EBIT Margin-30.15%
Analyst Forecast
The average price target for Enzo Biochem is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―